Related Experiment Video

Updated: May 18, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Differentiation between left bundle branch block and left ventricular hypertrophy: implications for cardiac

David G Strauss1

  • 1Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, USA. david.strauss@fda.hhs.gov

Journal of Electrocardiology
|October 2, 2012
PubMed

Insights

Cardiac resynchronization therapy (CRT) benefits patients with complete left bundle branch block (LBBB). Differentiating true LBBB from conditions like left ventricular hypertrophy (LVH) is crucial for effective CRT.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Diagnostics

Background:

  • Cardiac resynchronization therapy (CRT) improves outcomes in heart failure patients with complete left bundle branch block (LBBB).
  • Conventional electrocardiographic criteria may misdiagnose LBBB, potentially including patients with left ventricular hypertrophy (LVH) and delayed activation.
  • Distinguishing true LBBB from LVH is critical as CRT efficacy may differ.

Purpose of the Study:

  • To highlight the diagnostic challenges in differentiating complete LBBB from LVH and other intraventricular conduction delays.
  • To emphasize the clinical importance of accurate LBBB diagnosis for CRT patient selection.
  • To discuss proposed stricter criteria for diagnosing complete LBBB.

Main Methods:

  • Review of clinical trial data on CRT efficacy in different conduction abnormalities.
  • Analysis of endocardial mapping and simulation studies on LBBB misdiagnosis.
  • Examination of proposed new diagnostic criteria for complete LBBB.

Main Results:

  • CRT is effective in patients with complete LBBB but potentially not in those with RBBB or LVH-related conduction delays.
  • Approximately one-third of patients diagnosed with LBBB may be misdiagnosed, often having LVH with delayed LV activation.
  • Increased LV size and slowed conduction prolong QRS duration, mimicking LBBB in LVH patients.

Conclusions:

  • Accurate differentiation between complete LBBB and LVH is essential for optimizing CRT.
  • New diagnostic criteria for LBBB, including longer QRS duration thresholds and specific ECG findings, warrant further investigation.
  • Further research is needed to refine diagnostic approaches for intraventricular conduction delays in the context of CRT.

More Related Videos

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...